Mind the Byte is a young and innovative company founded in 2011 and specialized on computational drug discovery through its innovative SaaS platform and AI. The company has offices at the Barcelona Science Park and the Copenhagen Bioscience Park and also presence in Japan.
Mind the Byte is a bioinformatics company specialized in Computational Drug Discovery. The company offers solutions to improve and speed up the R&D process
and reduce its associated costs and risks. Mind the Byte is a young creative and entrepreneurial company, which is involved in R&D itself and constantly innovating. Currently, it is developing new applications using Machine Learning
and Big Data
approaches, which distances itself from the classical methods used in the field. The company targets the biopharmaceutical industry, as well as research groups from the public and private sector.
Mind the Byte has a scalable business model
and offers its technology via SaaS platform, which comes with ad-hoc support services. In addition, the company also offers scientific consultancy. Mind the Byte assists and helps their clients during the whole process of drug development. Moreover, it is a member of public-private consortiums that place Mind the Byte into the front line of technological development.
New funding round
Mind the Byte has recently opened a new funding round through the leading equity crowdfunding platform Crowdcube. With this new round, the company aims to raise between 450.000 and 500.000 euros to be invested on its business model development and expansion as well as on the development of future versions of its SasS platform.
Updates for shareholders
June 13th, 2017
Notice of the call for an Ordinary Shareholders meeting - June 29th at 3pm / Convocatoria de la Junta General Ordinaria de Socios - 29 de Junio a las 15h.